Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ: LIXT · Real-Time Price · USD
1.195
-0.015 (-1.24%)
At close: Apr 1, 2025, 4:00 PM
1.170
-0.025 (-2.09%)
After-hours: Apr 1, 2025, 4:19 PM EDT

LIXT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Selling, General & Admin
2.854.194.964.982.04
Upgrade
Research & Development
0.730.91.351.741.22
Upgrade
Operating Expenses
3.575.096.316.723.27
Upgrade
Operating Income
-3.57-5.09-6.31-6.72-3.27
Upgrade
Interest Expense
-0.02-0.02-0.01-0.01-0
Upgrade
Interest & Investment Income
0.010.020.0100
Upgrade
Currency Exchange Gain (Loss)
-00-0-00
Upgrade
EBT Excluding Unusual Items
-3.59-5.09-6.31-6.73-3.26
Upgrade
Pretax Income
-3.59-5.09-6.31-6.73-3.26
Upgrade
Net Income
-3.59-5.09-6.31-6.73-3.26
Upgrade
Net Income to Common
-3.59-5.09-6.31-6.73-3.26
Upgrade
Shares Outstanding (Basic)
22211
Upgrade
Shares Outstanding (Diluted)
22211
Upgrade
Shares Change (YoY)
17.41%21.10%17.41%19.48%0.92%
Upgrade
EPS (Basic)
-1.59-2.66-3.99-4.99-2.90
Upgrade
EPS (Diluted)
-1.59-2.66-3.99-4.99-2.90
Upgrade
EBIT
-3.57-5.09-6.31-6.72-3.27
Upgrade
Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q